GLP-1 weight-loss drugs, such as Ozempic, are reshaping the way consumers eat, prompting food and beverage manufacturers to develop precision nutrition solutions.
These solutions utilize AI and functional ingredients to personalize diets and target metabolism more effectively.
Precision nutrition involves aligning food intake with individual biological, metabolic, and behavioral characteristics.
The weight-loss revolution sparked by GLP-1 drugs like Ozempic and Mounjaro is driving this movement, transforming the food industry's relationship with biology.
Precision nutrition is about aligning what we eat with who we are – biologically, metabolically and behaviourally.
Author's summary: GLP-1 drugs drive precision nutrition.